IOBT
IO Biotech Inc
NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY
$0.05
+0.00% today
Updated 2026-04-07
Market cap
$2.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$0 – $3
Volume
14.5M
IO Biotech Inc (IOBT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $9.42M | $5.65M | $222.29M | $151.81M | $150.72M | $67.70M |
| Cash & equivalents | $7.85M | $3.40M | $211.53M | $142.59M | $143.19M | $60.03M |
| Current assets | $9.40M | $5.63M | $221.74M | $148.22M | $147.25M | $64.95M |
| Total liabilities | $10.89M | $3.05M | $10.36M | $12.95M | $17.56M | $20.68M |
| Current liabilities | $10.84M | $3.05M | $10.30M | $10.68M | $15.72M | $19.49M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-1.47M | $2.60M | $211.92M | $138.85M | $133.16M | $47.02M |
| Retained earnings | $-26.36M | $-38.40M | $-106.28M | $-177.74M | $-263.82M | $-359.31M |
| Accounts receivable | $1.23M | $1.50M | $2.09M | $1.53M | $1.13M | $1.13M |
| Inventory | $221000.00 | $359000.00 | $-2.09M | $-1.53M | — | — |
| Goodwill | — | — | — | — | — | — |